Inogen Inc (INGN) Stock Price

INGNStock

$6.25−26.56%52W

Market Cap$165.86M

P/E—

PEG Ratio—

Div yield—

Beta1.54

INGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-11.33%

Price vs S&P 500 (4W)23.87%

VGM Score51.27

P/CF (Annual)29.56x

Book Value / Share (Quarterly)$6.54

P/TBV (Annual)1.13x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-2.59%

Cash Flow / Share (Quarterly)$-0.36

Price vs S&P 500 (YTD)-18.92%

Gross Margin (TTM)44.51%

Net Profit Margin (TTM)-6.94%

EPS (TTM)$-0.90

10-Day Avg Trading Volume0.29M

EPS Excl Extra (TTM)$-0.90

Revenue Growth (5Y)2.48%

EPS (Annual)$-0.86

ROI (Annual)-11.83%

Gross Margin (Annual)44.24%

Net Profit Margin (5Y Avg)-14.73%

Cash / Share (Quarterly)$3.95

Revenue Growth QoQ (YoY)3.04%

ROA (Last FY)-7.62%

Revenue Growth TTM (YoY)3.15%

EBITD / Share (TTM)$-0.41

ROE (5Y Avg)-22.47%

Operating Margin (TTM)-8.71%

Cash Flow / Share (Annual)$-0.79

P/B Ratio0.95x

P/B Ratio (Quarterly)1.00x

Net Income / Employee (Annual)$-30,200

EV / Revenue (TTM)0.22x

Net Interest Coverage (TTM)26.25x

ROA (TTM)-8.36%

EV / EBITDA (TTM)12.88x

EPS Incl Extra (Annual)$-0.86

Current Ratio (Annual)3.12x

Quick Ratio (Quarterly)2.16x

3-Month Avg Trading Volume0.28M

52-Week Price Return-26.56%

Revenue / Employee (TTM)$470,500

Tangible BV / Share (Quarterly)$5.51

P/S Ratio (Annual)0.48x

Asset Turnover (Annual)1.17x

52-Week High$9.13

Operating Margin (5Y Avg)-15.20%

EPS Excl Extra (Annual)$-0.86

CapEx CAGR (5Y)-10.02%

Tangible BV CAGR (5Y)-10.48%

26-Week Price Return-1.42%

Quick Ratio (Annual)2.51x

13-Week Price Return-4.87%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.74x

Enterprise Value$78.59M

Revenue / Share Growth (5Y)-1.34%

Asset Turnover (TTM)1.20x

Book Value / Share Growth (5Y)-14.91%

Revenue / Employee (Annual)$463,000

Inventory Turnover (Annual)7.66x

Pretax Margin (Annual)-6.71%

Cash / Share (Annual)$4.39

3-Month Return Std Dev43.24%

Gross Margin (5Y Avg)44.09%

Net Income / Employee (TTM)$-32,700

ROE (Last FY)-11.83%

Net Interest Coverage (Annual)13.86x

EPS Basic Excl Extra (Annual)$-0.86

P/FCF (TTM)152.03x

Receivables Turnover (TTM)8.36x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.90

Receivables Turnover (Annual)10.19x

ROI (TTM)-13.17%

P/S Ratio (TTM)0.47x

Pretax Margin (5Y Avg)-13.93%

Revenue / Share (Annual)$13.11

Tangible BV / Share (Annual)$5.93

Price vs S&P 500 (52W)-42.09%

Year-to-Date Return-6.99%

5-Day Price Return-2.65%

EPS Normalized (Annual)$-0.86

ROA (5Y Avg)-14.63%

Net Profit Margin (Annual)-6.52%

Month-to-Date Return18.60%

Cash Flow / Share (TTM)$-5.02

EBITD / Share (Annual)$-0.95

Operating Margin (Annual)-8.66%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-22.47%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.90

P/TBV (Quarterly)1.18x

P/B Ratio (Annual)0.95x

Inventory Turnover (TTM)7.43x

Pretax Margin (TTM)-7.14%

Book Value / Share (Annual)$7.06

Price vs S&P 500 (13W)-7.56%

Beta1.54x

P/FCF (Annual)8.55x

Revenue / Share (TTM)$13.10

ROE (TTM)-13.17%

52-Week Low$5.04

vGradeB

gGradeD

mGradeC

vgmGradeC

INGN Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.06	$0.00	+100.00%(+$0.06)
Q1 2026	May 7, 2026	-$0.21	-$0.14	+33.33%(+$0.07)
Q4 2025	Feb 24, 2026	-$0.18	-$0.15	+16.67%(+$0.03)
Q3 2025	Nov 5, 2025	-$0.09	-$0.02	+77.78%(+$0.07)
Q2 2025	Aug 7, 2025	-$0.09	-$0.02	+77.78%(+$0.07)

INGN Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

4.13

Industry Peers — Orthopedic & Prosthetic Devices(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
INGNInogen Inc	B	D	C	0.5x	2.5%	44.5%	-8.7%	$6.25
ISRGIntuitive Surgical Inc.	D	B	B	13.7x	18.2%	66.7%	31.3%	$426.70
EWEdwards Lifesciences Corp	D	C	B	7.7x	6.7%	77.8%	18.2%	$86.60
STESTERIS plc	C	C	B	3.6x	13.8%	44.4%	18.9%	$222.66
ZBHZimmer Biomet Holdings, Inc.	B	C	B	2.1x	3.2%	69.9%	14.2%	$94.98
SNNSmith & Nephew plc	B	C	C	1.9x	6.2%	68.2%	12.9%	$29.06
ALGNAlign Technology Inc	B	D	C	2.5x	10.3%	69.0%	13.2%	$147.31
MSAMine Safety Incorporated	C	C	B	3.5x	6.8%	47.6%	21.2%	$179.05
ESTAEstablishment Labs Holdings Inc.	F	A	C	7.2x	20.0%	70.5%	-7.6%	$59.18
ENOVEnovis Corporation	B	D	C	0.5x	-6.0%	61.4%	-45.1%	$19.59
CDRECadre Holdings, Inc.	B	C	C	1.6x	8.6%	41.8%	10.1%	$26.38
AVRAnteris Technologies Global Corp. Common Stock	D	C	C	263.0x	—	75.0%	-4738.4%	$6.05
SMTISanara MedTech Inc. Common Stock	D	C	B	2.8x	45.9%	93.0%	7.7%	$33.16
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	F	D	C	6.3x	5.0%	29.2%	2.9%	$2.08
LAKELakeland Industries Inc	B	D	D	0.5x	3.9%	32.6%	-4.1%	$9.09
CNXUConexeu Sciences Inc. Common Stock	—	—	F	—	—	—	—	$3.06
NTRBNutriband Inc. Common Stock	F	D	B	46.7x	16.6%	33.1%	-435.6%	$6.22
SPAISafe Pro Group Inc. Common Stock	F	A	D	23.3x	—	62.2%	-513.8%	$3.30
APTAlpha Pro Tech, Ltd.	A	D	B	0.9x	-10.4%	37.5%	7.5%	$5.55
COCHEnvoy Medical, Inc. Class A Common Stock	F	F	C	249.8x	—	-385.5%	-11411.1%	$0.67
MYOMyomo Inc.	B	B	B	1.1x	40.1%	68.3%	-27.1%	$1.20
MLSSMilestone Scientific, Inc. Common Stock	D	C	C	3.1x	10.5%	70.2%	-43.6%	$0.33
LFWDLifeward Ltd. Ordinary Shares	A	C	C	1.1x	38.1%	32.9%	-125.5%	$6.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	F	196.5x	—	-0.4%	-9352.8%	$1.90
RGNTRegentis Biomaterials Ltd.	—	—	D	—	—	—	—	$1.49
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	D	F	C	17.6x	-17.3%	-147.6%	-3329.1%	$3.63
BBLGBone Biologics Corp Common Stock	—	—	F	—	—	—	—	$0.40
FEEDENvue Medical, Inc. Common Stock	—	F	F	0.2x	—	-26.1%	-1362.7%	$0.37
AVNSAvanos Medical, Inc.	B	D	B	1.6x	-0.4%	50.0%	-8.8%	$0.00
BBLGWBone Biologics Corp Warrants	—	—	D	—	—	—	—	$7.70
COCHWEnvoy Medical, Inc Warrant	—	—	D	—	—	—	—	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	—	—	—	—	$0.55

About Inogen Inc

Inogen Inc develops and manufactures respiratory care products for patients with chronic respiratory conditions, including portable and stationary oxygen concentrators, airway clearance devices, and CPAP masks. The company generates revenue through product sales and equipment rental services across its respiratory health solutions portfolio.

INGN Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.06

Revenue estimate$92.25M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

GPROGoPro, Inc.Photographic Equipment & Supplies
FOCLEDAP TMS S.A. American Depositary SharesElectromedical Equipment
PDEXPro-Dex Inc NewSurgical & Medical Instruments
RXSTRxSight, Inc. Common StockOphthalmic Goods
INTTinTEST CorporationInstruments for Measuring
STIMNeuronetics, Inc. Common StockSurgical & Medical Instruments
KRMDKORU Medical Systems, Inc. Common Stock (DE)Surgical & Medical Instruments
HURCHurco Cos IncIndustrial Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$5.04

High$9.13